Celgene Corporation (NASDAQ:CELG)
Sanford C. Bernstein Strategic Decisions Conference 2017
May 31, 2017 04:00 PM ET
Executives
Mark Alles - Chief Executive Officer
Analysts
Ronny Gal - Sanford C. Bernstein
Ronny Gal
Thank you very much for making it. My first introduction to Mark was when I showed up at the breakout session that the Company had at J. P. Morgan. And even then the name says on and was raising about how evil the men at the CBM are. And I could be opposite position that we got into an argument, and gets everybody around the table again to look at them, we decided that why are you arguing with them, which made me turn around and asked him, hi, I’m Ronny Gal, do you want to say. And at least I knew who I was at that point, but we also learned that Seals and Marine officer before early in his carrier and having served in a similar unit can certainly appreciate the feistiness that comes from -- that come back on.
Based on the Celgene preference, we’re going to start with a short statement by Mark about where the Company is today. And then I'm going to start through Q&A that kind of go through the major franchise and ask some general questions. And happy to take questions, there are cards on the table, please feel free to pass them on and somebody will come from the back and take them up. In the end of the 45-50 minutes we’ve got, I'm going to talk couple of things before end and see if anybody wants to just get out and ask questions directly. And if that’s okay, Mark thank you for being here.
